SEC Comment Letter for Apyx Medical (APYX) — May 9, 2018
Apyx Medical Corp
Date: May 9, 2018 · CIK: 0000719135 · Accession: 0000000000-18-014465
AI Filing Summary & Sentiment
File numbers found in text: 333-224677
Show Raw Text
Mail Stop 3030 May 9, 2018 Charles D. Goodwin, II Chief Executive Officer Bovie Medical Corporation 5115 Ulmerton Road Clearwater, Florida 33760 Re: Bovie Medical Corporation Registration Statement on Form S-3 Filed May 4 , 2018 File No. 333-224677 Dear Mr. Goodwin : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at (202) 551 -3635 with any questions. Sincerely, /s/ Tim Buchmiller for Amanda Ravitz Assistant Director Office of Electronics and Machinery cc: Adam P. Silvers, Esq. Ruskin Moscou Faltischek, P.C